Icahn School of Medicine at Mount Sinai
New York, 10029, United States
NCT Number: NCT02467530
This is an intervention study of the effects of food preparation on the gut bacteria in patients with end stage renal disease on peritoneal dialysis. This is a dietary intervention consistent of consuming low amounts of advanced glycation end products (AGEs), the products of protein and sugar interaction during food processing and preparation using high direct heat.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
New York, 10029, United States
Gut microbes can influence numerous aspects of human biology. Alterations in the function and composition of gut microbial flora (gut microbiota) have been linked to different diseases such as obesity, diabetes and inflammation. Advanced Glycation End products (AGEs) are formed via the Maillard reaction, which consists of a complex network of non-enzymatic reactions involving the carbonyl groups of reducing sugars which react with the amino groups of proteins. AGEs are produced in vivo and being consumed. They have been implicated in increased risk of different diseases including atherosclerosis, CAD and kidney diseases. In this study, the investigators are evaluating the effects of consuming a low AGE diet in participants on peritoneal dialysis on the gut bacteria and inflammation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Advanced Glycation End products
Time frame: baseline and 1 month
Change in AGE levels in the skin at 1 month compared to baseline will be measure using an AGE reader.
Time frame: baseline and 1 month
Change in serum AGE level at 1 month compared to baseline
Time frame: baseline and 1 month
Change in serum IL-2 level at 1 month compared to baseline
Time frame: baseline and 1 month
Change in serum CRP level at 1 month compared to baseline
Time frame: baseline and 1 month
Change in serum IL-10 level at 1 month compared to baseline
Time frame: baseline and 1 month
Change in serum creatinine level at 1 month compared to baseline
Time frame: baseline and 1 month
Change in serum BUN at 1 month compared to baseline
Time frame: baseline and 1 month
Change in serum p-cresol level at 1 month compared to baseline
Time frame: baseline and 1 month
Change in serum indoxyl sulfate level at 1 month compared to baseline
Time frame: baseline and 1 month
Change in serum vitamin D level at 1 month compared to baseline
Icahn School of Medicine at Mount Sinai
Other
Effect of a Low AGE Diet on Human Microbiome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07165015
Chronic Disease, Disease Attributes
Orlando, Florida, United States
View Trial DetailsNCT07531186
Chronic Disease, Disease Attributes
Al Mansurah, Dakahlia Governorate, Egypt
View Trial DetailsNCT07436559
Arteriovenous Fistula, Arteriovenous Malformations
Douliu, Taiwan
View Trial DetailsNCT07273825
Aromatherapy, Aromatherapy (Geranium Essential Oil)
Sukoharjo, Centre Java, Indonesia
View Trial Details